Trial intelligence / Profile preview

Auricular Pressure Beans and Electroacupuncture for Cancer-Induced Insomnia

NCT06859190Phase 3Recruiting

Sponsor
Qinghai Red Cross Hospital
Start
Mar 2025
Primary completion
Mar 2026
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Qinghai Red Cross Hospital. Primary endpoint: Insomnia Severity Index at 20 weeks. Started Mar 2025; status: recruiting.

Beyond the preview

Go deeper on NCT06859190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06859190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call